Abstract
The global market for nuclear medicine systems is composed of sales of
positron emission tomography/computed tomography (PET/CT) and single photon
emission computed tomography (SPECT) systems. In 2008, revenues in this market
declined sharply due to the onset of the global economic crisis as well as
reduced demand in the US, where the market is mature and existing systems are
not being used to capacity. Revenues in all three regions in this market will
continue to suffer in 2009 because of the economic crisis, government
restrictions in China, market maturity in western countries, and concerns over
low reimbursement rates. As the crisis recedes in 2010, however, the market
will stabilize, driven by replacement sales, increased PET/CT procedure
volumes- encouraged by benefits of PET/CT scanning in oncology- and adoption
of more expensive hybrid SPECT/CT systems- favored by facilities because of
their richer feature set. Despite this upturn, the global market for nuclear
medicine systems will experience a slight overall decrease over the forecast
period.
| 
View Cart
